Repetitive transcranial magnetic stimulation (rTMS) of the brain is a noninvasive, well-tolerated technique that can modify cerebral cortex ... rTMS for motor function in Parkinson disease ...

a common and debilitating complication of Parkinson’s disease treatment. The research explored how this condition affects the brain’s motor cortex and evaluated ketamine, an anesthetic ...

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex. Jef Akst was managing editor ...

Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced imaging techniques. Reactive astrogliosis is a response of astrocytes to ...

Now, using a novel system developed at Janelia, researchers led by the Dudman Lab found that a part of the basal ganglia called the striatum is not involved in action selection as previously thought.

US-based pharmaceutical company AbbVie has reported that the Phase III TEMPO-2 trial of tavapadon, its D1/D5 partial agonist candidate for early-stage Parkinson's disease, met its primary endpoint.

The primary endpoint was ... injuries in people living with Parkinson's disease. Pirepemat is designed to strengthen nerve cell signaling in the prefrontal cortex via antagonism at 5HT7 and ...